International Health
Volume 2, Issue 2 , Pages 156-159 , June 2010

Prevalence of rubella IgG antibodies among pregnant women in Zaria, Nigeria

  • Mohammed-Durosinlorun Amina

      Affiliations

    • Shehu Mohammed Kangiwa Medical Center, Kaduna Polytechnic, Kaduna, Nigeria
    • Corresponding Author InformationCorresponding author at: Formerly Department of Obstetrics and Gynaecology, Ahmadu Bello University Teaching Hospital, Zaria, Kaduna Tel.: +2348023669430.
    • ,
  • Shittu Oladapo

      Affiliations

    • Department of Obstetrics and Gynaecology, Ahmadu Bello University Teaching Hospital, Zaria, Kaduna, Nigeria
    • ,
  • Sadauki Habib

      Affiliations

    • Department of Obstetrics and Gynaecology, Aminu Kano University Teaching Hospital, Kano, Nigeria
    • ,
  • Olayinka Adebola

      Affiliations

    • Department of Medical Microbiology, Ahmadu Bello University Teaching Hospital, Zaria, Kaduna, Nigeria
    • ,
  • Kolawole Bimbo

      Affiliations

    • Department of Obstetrics and Gynaecology, Ahmadu Bello University Teaching Hospital, Zaria, Kaduna, Nigeria
    • ,
  • Adejo Daniel

      Affiliations

    • Department of Obstetrics and Gynaecology, Ahmadu Bello University Teaching Hospital, Zaria, Kaduna, Nigeria

Received 23 August 2009 ,Revised 1 January 2010 ,Accepted 29 March 2010.

References 

  1. Frei BJ, South MA, Sever JL. Maternal Rubella and the congenital Rubella syndrome. Clin perinatol. 1988;15:247–257
  2. Bukbuk DN, el Nafaty AU, Obed JY. Prevalence of Rubella-specific IgG antibody in non-immunised pregnant women in Maiduguri, North eastern Nigeria. Cent Eur J Public Health. 2002;10:21–23
  3. Olusanya O, Bloomberg J. Antibody prevalence against Rubella among hospital personnel in Nigeria: Implications for healthcare system and immunization policy. Acta Tropica. 1990;48:101–107
  4. Bamgboye AE, Afolabi KA, Esumeh FE, Enweani IB. Prevalence of Rubella antibody in pregnant women in Ibadan, Nigeria. West African J Med. 2004;23:445–448
  5. Gomwalk NE. Ezeronyeou. Seroepidermiology of Rubella in Imo state of Nigeria. Trans R Soc Trop Med Hyg. 1985;79:777–780
  6. Onyenekwe CC, Kehinde TA, Ofor US, Arinola OG. Prevalence of Rubella antibody in women of childbearing age in Lagos, Nigeria. West African J Med. 2000;19:23–26
  7. Lee JY, Bowden DS. Rubella virus replication and links to teratogenicity. Clin Microbiol Rev. 2000:13;571-87. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcenterz&artid=88950. [accessed 17 February 2008].
  8. Sadighi J, Eftekhar H, Mohammad K. Congenital Rubella syndrome in Iran. BMC Infect Dis. 2005; 5:44 http://www.biomedcentral.com/1471-2334/5/44. [accessed 17 February 2008].
  9. WHO. Rubella vaccines: WHO Position Paper Wkly Epidemiol Rec. 2000; 75:161-69.
  10. WHO. Kaduna office. Data from Preliminary results of measles serosurveillance 2007. http://www.who.int/immunization_monitoring/en/globalsummary/timeseries/tsincidencerub.htm. [accessed 17 February 2008].
  11. CDC. Measles–United States,1990. MMWR Morb Mortal Wkly Rep 1991; 40:369-72.
  12. Robertson SE, Featherstone DA, Gacic-Dobo M, Hersh BS. Rubella and congenital Rubella syndrome: global update. Rev Panam Salud Publica. 2003;14:306–315
  13. Shittu SO, Ebeigbe PN. Viral infections in pregnancy. In:  Okpere E editors. Clinical Obstetrics. Nigeria: Uniben Press. Rev. ed; 2004;p. 136–143
  14. Yadav S, Gupta S, Kumar S. Seroprevalence of Rubella in women of reproductive age. Indian J Pathol Microbiol. 1995;38:139–142
  15. Désinor OY, Ansèlme RJ, Laender F, Saint-Louis C, Bien-Aimé JE. Seroprevalence of antibodies against Rubella virus in pregnant women in Haiti. Rev Panam Salud Publica. 2004;15:145–146
  16. Ashrafunnessa KS, Islam MN, Chowdhury S. Seroprevalence of Rubella antigen among antenatal population attending tertiary level hospital in Dhaka city. Bangladesh Med Res Counc Bull. 2000;26:75–81
  17. Vyse AJ, Gay NJ, White JM, Ramsay ME, Brown DW, Cohen BJ, et al. Evolution of surveillance of measles, mumps and Rubella in England and Wales. Providing the platform for evidence based vaccination policy. Epidemiol Rev. 2002;24:1225–1236
  18. CDC. Outbreaks of rubella among the Amish–United States, 1991. MMWR 1991; 40:264-5.
  19. U.S. Preventive Services Task Force. Guide to Clinical Preventive Services, 2nd ed. Washington, DC: Office of Disease Prevention and Health Promotion; 1996.
  20. Dyne P. Pediatrics, Rubella. http://emedicine.medscape.com/article/802617-overview [accessed 17 February 2008].
  21. Sheridan E, Aitken C, Jeffries D, Hird M, Thayalasekaran P. Congenital Rubella syndrome: A risk in emigrant populations. Lancet. 2002;359:674–675
  22. Gomwalk NE, Ahmad AA. Prevalence of Rubella antibodies on the African Continent. Rev infect Dis. 1989;11:116–121
  23. Otaigbe BE, Brown T, Esu R. Confirmed congenital Rubella syndrome–a case report. Nig J Med. 2006;15:448–450
  24. Robinson JL, Lee BE, Preiksaitis JK, Plitt S, Tipples GAl. Prevention of congenital rubella syndrome–what makes sense in 2006?. Epidemiol Rev. 2006;28:81–87
  25. Odelola HA. Rubella haemaglutination-inhibition antibody in females of child-bearing age in western Nigeria. J Hyg Epidemiol Microbiol Immunol. 1978;22:190–194
  26. National Population Commission, Federal Republic of Nigeria. Nigeria Demographic and Health Survey 2008: preliminary report. http://pdf.usaid.gov/pdf_docs/PNADO566.pdf. [accessed 1 January 2010].
  27. Fatusi AO, Ijadunola KT. National study on essential obstetric care facilities in Nigeria: Technical report. Nigeria: Federal Ministry of Health; 2003.
  28. Odelola HA, Fabiyi A, Familusi JB. Distribution of rubella antibodies in Nigeria. Trans R Soc Trop Med Hyg. 1977;71:425–426

PII: S1876-3413(10)00023-9

doi: 10.1016/j.inhe.2010.03.004

International Health
Volume 2, Issue 2 , Pages 156-159 , June 2010

Article Tools